Log In
Print
BCIQ
Print
Print this Print this
 

Lu AA24493

  Manage Alerts
Collapse Summary General Information
Company H. Lundbeck A/S
DescriptionCarbamoylated form of human erythropoietin (EPO)
Molecular Target Erythropoietin (EPO) receptor
Mechanism of Action 
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today